| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kwon A et al. | Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. | 2016 | Medicine (Baltimore) | pmid:27082605 |
| Hsu BG et al. | Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. | 2016 | Medicine (Baltimore) | pmid:27082570 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
| Kobayashi Y et al. | Regulation of bone metabolism by Wnt signals. | 2016 | J. Biochem. | pmid:26711238 |
| Chen Z et al. | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. | 2016 | Int. J. Mol. Med. | pmid:26677102 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
| Meijome TE et al. | C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. | 2016 | J. Cell. Biochem. | pmid:26375403 |
| Pietschmann P et al. | Immunology of Osteoporosis: A Mini-Review. | 2016 | Gerontology | pmid:26088283 |
| Ostrowska Z et al. | TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. | 2016 | Endokrynol Pol | pmid:27828689 |
| Kan C et al. | Cancer Cell Colonisation in the Bone Microenvironment. | 2016 | Int J Mol Sci | pmid:27782035 |
| Huang HM et al. | Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. | 2016 | Chin. Med. J. | pmid:27779163 |
| Kamata R et al. | EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. | 2016 | PLoS ONE | pmid:27764222 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| Li B et al. | Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. | 2016 | Int J Mol Sci | pmid:27110777 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Widschwendter M et al. | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629528 |
| Rachner TD and Rauner M | RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629502 |
| Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
| Silva Vde O et al. | β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. | 2015 | PLoS ONE | pmid:26291983 |
| Darabi H et al. | Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. | 2015 | Medicine (Baltimore) | pmid:26287420 |
| Gennaro G et al. | Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. | 2015 | PLoS ONE | pmid:26270535 |
| Niu Y et al. | Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. | 2015 | BMC Cardiovasc Disord | pmid:26260869 |
| Weichhaus M et al. | Osteoprotegerin in breast cancer: beyond bone remodeling. | 2015 | Mol. Cancer | pmid:26054853 |
| Kastritis E et al. | Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. | 2015 | Blood Cancer J | pmid:26047389 |
| Janda K et al. | Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. | 2015 | BMC Nephrol | pmid:26037625 |
| Davenport C et al. | The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. | 2015 | Eur. J. Endocrinol. | pmid:26036811 |
| Harrison R et al. | Acute bone response to whole body vibration in healthy pre-pubertal boys. | 2015 | J Musculoskelet Neuronal Interact | pmid:26032203 |
| Goyden J et al. | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. | 2015 | PLoS ONE | pmid:26030441 |
| Zhao L et al. | Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. | 2015 | J. Nutr. Biochem. | pmid:26239832 |
| Qiao B et al. | Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. | 2015 | Drug Des Devel Ther | pmid:25733814 |
| Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
| de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
| Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Kuroyanagi G et al. | Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. | 2015 | Mol Med Rep | pmid:26044505 |
| Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
| Maser RE et al. | Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. | 2015 | Endocr Pract | pmid:25100392 |